SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001016169-08-000019
Filing Date
2008-03-26
Accepted
2008-03-26 16:46:28
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 k10b.htm 10-K 2813813
2 GRAPHIC img1.gif GRAPHIC 14188
3 ex211.htm EX-21 9167
4 ECHIBIT 23.1 ex231.htm EX-23 5316
5 EXHIBIT 31.1 ex311new.htm EX-31 23499
6 EXHIBIT 31.2 ex312new.htm EX-31 23543
7 EXHIBIT 32.1 ex321.htm EX-32 10082
8 EXHIBIT 32.2 ex322.htm EX-32 10120
  Complete submission text file 0001016169-08-000019.txt   2916946
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32302 | Film No.: 08712532
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10